Inclusion Criteria:  All RA patients in our biologics registry treated with the JAK inhibitors (N=411) All RA patients in our biologics registry treated with the TNF inhibitors (N=1392)  Exclusion Criteria:  - RA patients in our biologics registry treated with other biologic/targeted DMARDs